Related Articles
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
Antitumor effect of gefitinib on head and neck squamous cell carcinoma enhanced by trastuzumab
Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma
Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT inhibition in bypassing this resistance
Co-treatment of wild‑type EGFR head and neck cancer cell lines with afatinib and cisplatin